EPIC ORDER CODE LAB5111 Amino Acids, Quantitative, Spinal Fluid
Additional Codes
SQ: AACSFM
Reporting Name
Amino Acids, QN, CSFUseful For
Evaluating patients with possible inborn errors of amino acid metabolism, particularly nonketotic hyperglycinemia (glycine encephalopathy) and serine biosynthesis defects, especially when used in conjunction with concomitantly collected plasma specimens
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
CSFAdditional Testing Requirements
This test should be ordered in conjunction with AAQP / Amino Acids, Quantitative, Plasma. The specimens for both tests (AAQP / Amino Acids, Quantitative, Plasma and this test) should be collected at the same time.
Necessary Information
1. Patient's age is required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information
Specimen Required
Container/Tube: Sterile vial
Specimen Volume: 0.2 mL
Collection Instructions: Collect specimen from second collection vial.
Specimen Minimum Volume
0.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Frozen | 14 days |
Reference Values
Amino Acid |
Age groups |
|||
≤31 days |
32 days-23 months |
2-18 years |
≥19 years |
|
Taurine (Tau) |
8-28 |
4-13 |
4-10 |
3-9 |
Asparagine (Asn) |
7-25 |
5-17 |
4-12 |
5-14 |
Serine (Ser) |
43-127 |
37-87 |
22-57 |
18-58 |
Hydroxyproline (Hyp) |
<12 |
<8 |
<3 |
<3 |
Glycine (Gly) |
<60 |
<27 |
<20 |
<28 |
Glutamine (Gln) |
447-1547 |
384-716 |
375-770 |
452-1283 |
Aspartic Acid (Asp) |
<12 |
<12 |
<12 |
<12 |
Ethanolamine (EtN) |
11-152 |
6-41 |
7-25 |
6-24 |
Histidine (His) |
19-63 |
12-32 |
9-26 |
12-36 |
Threonine (Thr) |
35-212 |
19-89 |
13-51 |
13-57 |
Citrulline (Cit) |
<6 |
<5 |
<4 |
<4 |
Sarcosine (Sar) |
<21 |
<21 |
<21 |
<21 |
Beta-alanine (bAla) |
<17 |
<17 |
<17 |
<17 |
Alanine (Ala) |
20-92 |
18-69 |
16-54 |
22-80 |
Glutamic Acid (Glu) |
<12 |
<4 |
<3 |
<2 |
1-Methylhistidine (1MHis) |
<5 |
<1 |
<1 |
<3 |
3-Methylhistidine (3MHis) |
<4 |
<1 |
<3 |
<5 |
Argininosuccinic Acid (Asa) |
<4 |
<4 |
<4 |
<4 |
Homocitrulline (Hcit) |
<1 |
<1 |
<1 |
<1 |
Arginine (Arg) |
7-37 |
11-36 |
13-30 |
14-32 |
Alpha-aminoadipic Acid (Aad) |
<2 |
<2 |
<2 |
<2 |
Gamma-amino-n-butyric Acid (GABA) |
<10 |
<10 |
<10 |
<10 |
Beta-aminoisobutyric Acid (bAib) |
<1 |
<1 |
<1 |
<1 |
Alpha-amino-n-butyric Acid (Abu) |
<21 |
<7 |
<5 |
<10 |
Hydroxylysine (Hyl) |
<1 |
<1 |
<1 |
<1 |
Proline (Pro) |
<14 |
<4 |
<4 |
<2 |
Ornithine (Orn) |
<32 |
<15 |
<12 |
<15 |
Cystathionine (Cth) |
<4 |
<1 |
<1 |
<2 |
Cystine (Cys) |
<3 |
<3 |
<3 |
<3 |
Lysine (Lys) |
16-67 |
17-41 |
13-45 |
23-54 |
Methionine (Met) |
<19 |
<7 |
<5 |
<12 |
Valine (Val) |
16-83 |
10-36 |
10-27 |
13-52 |
Tyrosine (Tyr) |
<70 |
<22 |
<16 |
<65 |
Isoleucine (Ile) |
2-30 |
2-14 |
3-11 |
3-17 |
Leucine (Leu) |
14-72 |
9-25 |
8-23 |
10-53 |
Phenylalanine (Phe) |
9-49 |
7-18 |
5-18 |
8-23 |
Tryptophan (Trp) |
<14 |
<14 |
<14 |
<14 |
Allo-isoleucine (AlloIle) |
<2 |
<2 |
<2 |
<2 |
All results reported in nmol/mL
Day(s) Performed
Monday through Friday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82139
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
AACSF | Amino Acids, QN, CSF | 35507-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
50435 | Interpretation | 49303-1 |
81934 | Taurine | 26614-8 |
30109 | Asparagine | 26603-1 |
30108 | Serine | 22644-9 |
34566 | Hydroxyproline | 26596-7 |
30115 | Glycine | 22650-6 |
30111 | Glutamine | 22641-5 |
34567 | Aspartic Acid | 22655-5 |
34568 | Ethanolamine | 26593-4 |
30128 | Histidine | 9453-2 |
30107 | Threonine | 22643-1 |
30117 | Citrulline | 22654-8 |
34569 | Sarcosine | 26598-3 |
34570 | Beta-alanine | 26589-2 |
30116 | Alanine | 22657-1 |
30110 | Glutamic Acid | 22652-2 |
34571 | 1-Methylhistidine | 26584-3 |
34572 | 3-Methylhistidine | 26585-0 |
34573 | Argininosuccinic Acid | 40838-5 |
34576 | Homocitrulline | 55875-9 |
30129 | Arginine | 22656-3 |
34577 | Alpha-aminoadipic Acid | 26587-6 |
34578 | Gamma-amino-n-butyric Acid | 26594-2 |
34579 | Beta-aminoisobutyric Acid | 26590-0 |
30118 | Alpha-amino-n-butyric Acid | 26586-8 |
34580 | Hydroxylysine | 26595-9 |
30112 | Proline | 22645-6 |
30126 | Ornithine | 22647-2 |
34581 | Cystathionine | 26592-6 |
30120 | Cystine | 22653-0 |
30127 | Lysine | 22651-4 |
30121 | Methionine | 22648-0 |
30119 | Valine | 22649-8 |
30124 | Tyrosine | 22642-3 |
30122 | Isoleucine | 22659-7 |
30123 | Leucine | 9412-8 |
30125 | Phenylalanine | 22646-4 |
34582 | Tryptophan | 26602-3 |
34583 | Allo-isoleucine | 22658-9 |
Clinical Information
Amino acids are the basic structural units that comprise proteins and are found throughout the body. Many inborn errors of amino acid metabolism that affect amino acid transport and metabolism have been identified. Amino acid disorders can manifest at any age, but most become evident in infancy or early childhood. These disorders result in the accumulation or deficiency of 1 or more amino acids in biological fluids, which leads to the clinical signs and symptoms of the specific amino acid disorder.
The clinical presentation is dependent upon the specific amino acid disorder. In general, affected patients may experience failure to thrive, neurologic symptoms, digestive problems, dermatologic findings, and physical and cognitive delays. If not diagnosed and treated promptly, amino acid disorders can result in intellectual disabilities and, possibly, death.
Cerebrospinal fluid (CSF) specimens are highly informative for a subset of these conditions, such as nonketotic hyperglycinemia and serine biosynthesis defects. CSF specimens are most informative when a plasma specimen is collected at the same time, and the ratio of the amino acid concentrations in CSF to those in plasma is calculated.
Interpretation
When no significant abnormalities are detected, a simple descriptive interpretation is provided. When abnormal results are detected, a detailed interpretation is provided. This interpretation includes an overview of the results and their significance, a correlation to available clinical information, elements of differential diagnosis, recommendations for additional biochemical testing and in vitro confirmatory studies (enzyme assay, molecular analysis), name and phone number of key contacts who may provide these studies, and the telephone number to reach one of the laboratory directors in case the referring physician has additional questions.
Clinical Reference
1. Rinaldo P, Hahn S, Matern D. Inborn errors of amino acid, organic acid, and fatty acid metabolism. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnosis. 4th ed. WB Saunders Company; 2005:2207-2247
2. Van Hove JLK, Coughlin C II, Swanson M, et al. Nonketotic hyperglycinemia. In: Adam MP, Feldman J, Mirzaa GM, et al, eds. GeneReviews [Internet]. University of Washington, Seattle; 2002. Updated May 23, 2019. Accessed October 24, 2024. Available at www.ncbi.nlm.nih.gov/books/NBK1357/
3. El-Hattab AW. Serine biosynthesis and transport defects. Mol Genet Metab. 2016;118(3):153-159. doi:10.1016/j.ymgme.2016.04.010
4. Pasquali M, Longo N. Amino acids. In: Blau N, Dionisi Vici C, Ferreira CR, Vianey-Saban C, van Karnebeek CDM, eds. Physician's Guide to the Diagnosis, Treatment and Follow-up of Inherited Metabolic Diseases. 2nd ed. Springer-Verlag; 2022:41-50
Method Description
Quantitative analysis of amino acids (AA) is performed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Patient samples are combined with isotopically labeled internal standard. Following protein precipitation, the supernatant is subjected to hydrophilic-interaction liquid chromatography for the separation of isomers with MS/MS detection of the underivatized amino acids. (Unpublished Mayo method)
Report Available
3 to 5 daysSpecimen Retention Time
2 weeksReject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Testing Algorithm
Testing includes quantitation of the following amino acids: taurine, threonine, serine, hydroxyproline, asparagine, glutamic acid, 1-methylhistidine, 3-methylhistidine, argininosuccinic acid, homocitrulline, alpha-aminoadipic acid, gamma-amino-n-butyric acid, beta-aminoisobutyric acid, alpha-amino-n-butyric acid, hydroxylysine, glutamine, aspartic acid, ethanolamine, proline, glycine, alanine, citrulline, sarcosine, beta-alanine, alpha-amino-n-butyric acid, valine, cystine, methionine, isoleucine, leucine, tyrosine, phenylalanine, ornithine, cystathionine, tryptophan, allo-isoleucine, lysine, histidine, and arginine.
For more information see Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm.
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Special Instructions
Forms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.